FMED
Fidelity Disruptive Medicine ETF
Positions 72Top 10 33.2%As of Aug 31, 2026
Fund holdings · Fidelity Disruptive Medicine ETF

FMED holdings: all 72 positions

Share
Share on XDownload as PDF

As of Aug 31, 2026, FMED’s top 10 holdings were 33.2% of the fund, led by 10X Genomics Inc at 5.19%. It held 72 positions.

askIQ about this page

askIQ about FMED holdings
How much of the fund each position is · one bar per position, largest first
TXG 5.19%72 positionsANNX 0.23%
33.2%
top 10 together
5.19%
largest position
31
positions under 1%
Holdings

What FMED holds

Pick a view. Open a holding for every fund that owns it.

Top 10
  1. TXG10X Genomics Inc
    5.19%
  2. TMOThermo Fisher Scientific Inc
    3.83%
  3. DHRDanaher Corp
    3.73%
  4. NTRANatera Inc
    3.30%
  5. ARGXArgenx SE
    3.20%
  6. LFSTLifeStance Health Group Inc
    3.00%
  7. RVMDRevolution Medicines Inc
    2.87%
  8. ILMNIllumina Inc
    2.82%
  9. MRNAModerna Inc
    2.72%
  10. HTFLHeartFlow Inc
    2.59%
  1. Health care
    91.3%
  2. Technology
    0.9%

92% of the weight read, book dated 2026-08-31

  1. United States
    81.1%
  2. Netherlands
    4.4%
  3. Cayman Islands
    2.6%
  4. France
    2.6%
  5. Bermuda
    2.2%
  6. Denmark
    2.0%
  7. Other
    4.9%

Most holdings in common with FMED

Share of weight both funds hold, from books dated Aug 31, 2026.

72 of 72 positions

Download holdings (CSV)JSON
72 of 72 · click a column to sort
FMED’s 72 positions by weight, from the holdings filed for Aug 31, 2026. A weight is a share of net assets. Source: Form N-PORT filed with the SEC.
#HoldingTickerWeight
110X Genomics IncTXG5.19%
2Thermo Fisher Scientific IncTMO3.83%
3Danaher CorpDHR3.73%
4Natera IncNTRA3.30%
5Argenx SEARGX3.20%
6LifeStance Health Group IncLFST3.00%
7Revolution Medicines IncRVMD2.87%
8Illumina IncILMN2.82%
9Moderna IncMRNA2.72%
10HeartFlow IncHTFL2.59%
11Sartorius Stedim BiotechDIM EPA2.56%
12Alnylam Pharmaceuticals IncALNY2.33%
13Cogent Biosciences IncCOGT2.31%
14Intuitive Surgical IncISRG2.05%
15Ascendis Pharma A/SASND1.97%
16Kymera Therapeutics IncKYMR1.96%
17Insmed IncINSM1.84%
18Vaxcyte IncPCVX1.83%
19Kiniksa Pharmaceuticals International PLCKNSA1.83%
20Edwards Lifesciences CorpEW1.76%
21West Pharmaceutical Services IncWST1.72%
22Veeva Systems IncVEEV1.66%
23UCB SAUCB EBR1.60%
24UnitedHealth Group IncUNH1.59%
25Amylyx Pharmaceuticals IncAMLX1.54%
26Guardant Health IncGH1.53%
27Caris Life Sciences IncCAI1.48%
28Repligen CorpRGEN1.48%
29Legend Biotech CorpLEGN1.45%
30BrightSpring Health Services IncBTSG1.45%
31Viridian Therapeutics IncVRDN1.40%
32Twist Bioscience CorpTWST1.35%
33Enliven Therapeutics IncELVN1.35%
34Boston Scientific CorpBSX1.14%
35Kestra Medical Technologies IncKMTS1.10%
36Roivant Sciences LtdROIV1.09%
37Xenon Pharmaceuticals IncXENE1.08%
38Oruka Therapeutics IncORKA1.08%
39Axsome Therapeutics IncAXSM1.06%
40Disc Medicine IncIRON1.06%
41Veracyte IncVCYT1.01%
42Stoke Therapeutics IncSTOK0.95%
43Waystar Holding CorpWAY0.91%
44ELI LILLY and COLLY0.89%
45Relay Therapeutics IncRLAY0.86%
46MBX Biosciences IncMBX0.84%
47Dianthus Therapeutics IncDNTH0.82%
48IRhythm Holdings IncIRTC0.80%
49Alumis IncALMS0.80%
50Zai Lab LtdZLAB0.75%
51Newamsterdam Pharma Company NVNAMS0.74%
52CytomX Therapeutics IncCTMX0.73%
53Dexcom IncDXCM0.71%
54Praxis Precision Medicines IncPRAX0.68%
55Zenas Biopharma IncZBIO0.62%
56Bruker CorpBRKR0.61%
57Alignment Healthcare IncALHC0.58%
58Braveheart Bio IncBRVE0.49%
59Pharvaris BvPHVS0.48%
60Spyre Therapeutics IncSYRE0.45%
61Mirum Pharmaceuticals IncMIRM0.42%
62Janux Therapeutics IncJANX0.42%
63Structure Therapeutics IncGPCR0.41%
64CG oncology IncCGON0.41%
65Climb Bio IncCLYM0.38%
66Definium Therapeutics IncDFTX0.37%
67Viking Therapeutics IncVKTX0.34%
68Upstream Bio IncUPB0.32%
69Jade Biosciences IncJBIO0.31%
70Olema Pharmaceuticals IncOLMA0.30%
71Outset Medical IncOM0.25%
72Annexon IncANNX0.23%
Cash and other net assets0.23%

Source: the fund’s SEC filing (Form N-PORT). Data as of Aug 31, 2026. Updated when the fund files its next report. Report a data error

The book
Positions72
Holdings as of (SEC N-PORT)Aug 31, 2026
Top 10 together33.2%
Cash and other net assets0.23%

By country

United States81.1%
Netherlands4.4%
Cayman Islands2.6%
France2.6%
Bermuda2.2%
Denmark2.0%
Other4.9%

Share of the fund, positions only, as the fund’s SEC filing states them.

Alert

Email me when FMED's holdings change.

Confirm by email. One a day at most, and one click stops it. See Privacy.

What this list is

Each weight is the share of net assets the fund’s SEC filing gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract.

How books are read →
Cite this pageCitation, APA and Markdown

ETFIQ, Holdings of FMED, data as of Aug 31, 2026. https://etfiq.com/funds/fmed/holdings/

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.